Innovating Works

UdA

Desconocido
LEUKOTREAT: Therapeutic challenge in Leukodystrophies Translational and ethical research towards clinical trial... UNIVERSITE DAUVERGNE CLERMONTFERRAND 1 tramitó un FP7: Leukodystrophies (LDs) are inherited rare neurodegenerative diseases of the white matter and its main component, the myelin, that are affect...
Financiado
IBDASE: Mucosal protease and their inhibitors in inflammatory bowel disease From etiopathogenetic insight t... UNIVERSITE DAUVERGNE CLERMONTFERRAND 1 participó en un FP7: IBDase addresses the etiology and pathogenesis of inflammatory bowel disease (IBD) with a multidisciplinary plan for innovative diagnosis an...
Financiado
MiRNA-AIEC: Role of microRNAs in host responses to Crohn s disease associated adherent invasive Escherichia coli UNIVERSITE DAUVERGNE CLERMONTFERRAND 1 participó en un FP7: Recent studies have shown dysregulation of microRNAs (miRNAs) in the mucosa of Crohn’s disease (CD) patients, suggesting a role for miRNAs a...
Financiado
FLEXABLE: Deformable Multiple View Geometry and 3D Reconstruction with Application to Minimally Invasive Surg... UNIVERSITE DAUVERGNE CLERMONTFERRAND 1 participó en un FP7: Project FLEXABLE lies in the field of 3D Computer Vision, which seeks to recover depth or the 3D shape of the observed environment from imag...
Financiado
MEAD-ET: Novel medical adsorbents for extracorporeal treatment of life threatening conditions UNIVERSITE DAUVERGNE CLERMONTFERRAND 1 participó en un FP7: Recently a program of development of super active carbonic adsorbents for the deep purification of whole blood and blood plasma was realised...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.